Clinical Trial Update: Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary Intervention [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining low-dose versus regular-dose aspirin in acute coronary syndrome patients at high risk after percutaneous coronary interv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Aspirin (Aspirin)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Fu Wai Hospital, Beijing, China | Conditions: Acute Coronary Syndrome, Interventional Cardiology | Phase 4 | Status: RECRUITING